Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention
26 May 2019 (08:30 - 18:00)
Organised by:
Abstract
About the speaker
Medical University of Warsaw, Warsaw (Poland)
20 More presentations in this session
Access the full session
The Event
Heart Failure 2019
26 May 2019
08:30 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
